none9noHairy cell leukemia (HCL) patients could have an excellent prognosis with adequate treatment. Treatments are not generally curative but are extremely effective in inducing long-lasting clinical remissions. An observational retrospective study was conducted on a single-center registry of 144 patients with a median follow-up of 11.5 years, focusing on long-lasting continuous first complete remissions (CR) wondering if patients can be cured only with front-line approach. CR for more than 5 years after first-line therapy were found in 22.2 \% cases. The median duration of response was 9.8 years, while for relapsed patients, the first response had a median duration of 2.4 years. Three different subsets of long-lasting first CR were identi...
: Hairy cell leukemia (HCL) is a rare lymphoproliferative disease with an excellent prognosis after ...
Between January 1991 and January 1994, 40 patients with hairy-cell leukemia (HCL), 30 males and 10 f...
: Cladribine is regarded as the first treatment of choice of symptomatic hairy cell leukemia (HCL): ...
Hairy cell leukemia (HCL) patients could have an excellent prognosis with adequate treatment. Treatm...
BACKGROUND: Historically, the first treatment choices for hairy cell leukemia (HCL) were splenectomy...
BACKGROUND: Historically, the first treatment choices for hairy cell leukemia (HCL) were splenectomy...
The treatment of hairy cell leukemia (HCL) has considerably changed over years. Purine analogues, na...
Classic hairy cell leukemia (HCL) is a rare indolent B-cell lymphoproliferative disorder characteriz...
International audienceAbstract In total, 279 patients with hairy-cell leukemia (HCL) were analyzed, ...
We aimed to analyze the characteristics and response rates of different treatment modalities in hair...
International audienceThere are limited population-based studies of hairy cell leukemia (HCL), a rar...
Although the nucleoside analogs cladrib-ine and pentostatin produce high re-sponse rates in patients...
The description of hairy cell leukemia as a specific clinical entity was published 50 years ago. The...
BACKGROUND: Both pentostatin and cladribine have efficacy in hairy cell leukemia (HCL), but it is no...
: Hairy cell leukemia (HCL) is a rare lymphoproliferative disease with an excellent prognosis after ...
Between January 1991 and January 1994, 40 patients with hairy-cell leukemia (HCL), 30 males and 10 f...
: Cladribine is regarded as the first treatment of choice of symptomatic hairy cell leukemia (HCL): ...
Hairy cell leukemia (HCL) patients could have an excellent prognosis with adequate treatment. Treatm...
BACKGROUND: Historically, the first treatment choices for hairy cell leukemia (HCL) were splenectomy...
BACKGROUND: Historically, the first treatment choices for hairy cell leukemia (HCL) were splenectomy...
The treatment of hairy cell leukemia (HCL) has considerably changed over years. Purine analogues, na...
Classic hairy cell leukemia (HCL) is a rare indolent B-cell lymphoproliferative disorder characteriz...
International audienceAbstract In total, 279 patients with hairy-cell leukemia (HCL) were analyzed, ...
We aimed to analyze the characteristics and response rates of different treatment modalities in hair...
International audienceThere are limited population-based studies of hairy cell leukemia (HCL), a rar...
Although the nucleoside analogs cladrib-ine and pentostatin produce high re-sponse rates in patients...
The description of hairy cell leukemia as a specific clinical entity was published 50 years ago. The...
BACKGROUND: Both pentostatin and cladribine have efficacy in hairy cell leukemia (HCL), but it is no...
: Hairy cell leukemia (HCL) is a rare lymphoproliferative disease with an excellent prognosis after ...
Between January 1991 and January 1994, 40 patients with hairy-cell leukemia (HCL), 30 males and 10 f...
: Cladribine is regarded as the first treatment of choice of symptomatic hairy cell leukemia (HCL): ...